Hopeful
06-17-2015, 06:11 AM
This is a Medscape article, which requires free registration to access:
http://www.medscape.com/viewarticle/846560
Of interest:
Further analyses linked DDT to advanced stage at diagnosis (estimated OR, 2.2; 95% CI, 1.1 - 4.2; P = .2) and to HER2-positive tumors (estimated OR, 2.1; 95 CI, 1.0 - 4.8; P = .05).
Daughters of women with triple the amount of exposure to DDT had four times the risk of developing advanced-stage and HER2-positive breast cancer compared with daughters of women with lower levels of exposure (for late-stage: OR, 4.6; 95% CI, 1.3 - 16.5; for HER2-positive: OR, 4.6; 95% CI, 1.1 - 19.7).
Laboratory studies have provided support for these findings and suggest that DDT activates the HER2 receptor, write the authors in their article, published online (http://press.endocrine.org/doi/10.1210/jc.2015-1841) June 16 in the Journal of Clinical Endocrinology and Metabolism.
Hopeful
http://www.medscape.com/viewarticle/846560
Of interest:
Further analyses linked DDT to advanced stage at diagnosis (estimated OR, 2.2; 95% CI, 1.1 - 4.2; P = .2) and to HER2-positive tumors (estimated OR, 2.1; 95 CI, 1.0 - 4.8; P = .05).
Daughters of women with triple the amount of exposure to DDT had four times the risk of developing advanced-stage and HER2-positive breast cancer compared with daughters of women with lower levels of exposure (for late-stage: OR, 4.6; 95% CI, 1.3 - 16.5; for HER2-positive: OR, 4.6; 95% CI, 1.1 - 19.7).
Laboratory studies have provided support for these findings and suggest that DDT activates the HER2 receptor, write the authors in their article, published online (http://press.endocrine.org/doi/10.1210/jc.2015-1841) June 16 in the Journal of Clinical Endocrinology and Metabolism.
Hopeful